ID

40954

Descrizione

The primary focus of this first time in human (FTIH) study was to evaluate the safety and tolerability of GSK1292263 and to estimate GSK1292263 pharmacokinetic (PK) parameters and pharmacodynamic (PD) effects in healthy volunteers. Subject: FTIH, oral, safety, tolerability, pharmacokinetics, glucose, pharmacodynamics, male, female, gastric emptying Indication Studied: Type 2 Diabetes Mellitus Study ID: 111596 Clinical Study ID: 111596 Study Title: A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00783549 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK1292263, Sitagliptin Trade Name: N/A Study Indication: Dyslipidaemias

Keywords

versioni (2)
  1. 25/04/20 25/04/20 -
  2. 07/06/20 07/06/20 -
Titolare del copyright

GlaxoSmithKline

Caricato su

7 giugno 2020

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin

Inglese

Pharmacokinetics (Liver PK), Liver Event 4-DF

1 moduli  
An unscheduled PK blood sample must be obtained within 24 hours of last dose (or 3x the investigational product half-life or t1/2; protocol specified longer value to be inserted).
Descrizione

An unscheduled PK blood sample must be obtained within 24 hours of last dose (or 3x the investigational product half-life or t1/2; protocol specified longer value to be inserted).

Alias
UMLS CUI-1
C3854240
UMLS CUI-2
C0031327
UMLS CUI-3
C0005834
UMLS CUI-4
C3843067
UMLS CUI-5
C0946444
UMLS CUI-6
C0013230
1. Was a pharmacokinetic blood sample obtained?
Descrizione

pharmacokinetic blood sample

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0005834
If yes, date sample taken
Descrizione

date blood sample taken

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0005834
UMLS CUI [1,2]
C0011008
If yes, time sample taken
Descrizione

time blood sample taken

Tipo di dati

time

Alias
UMLS CUI [1,1]
C0005834
UMLS CUI [1,2]
C0040223
If Yes, date of last investigational product dose prior to PK sample
Descrizione

date last investigational product dose prior to PK sample

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C1517741
UMLS CUI [1,3]
C0678766
UMLS CUI [1,4]
C0013230
UMLS CUI [1,5]
C0332152
UMLS CUI [1,6]
C0031328
UMLS CUI [1,7]
C0178913
If Yes, time of last investigational product dose prior to PK sample
Descrizione

time last investigational product dose prior to PK sample

Tipo di dati

time

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C1517741
UMLS CUI [1,3]
C0678766
UMLS CUI [1,4]
C0013230
UMLS CUI [1,5]
C0332152
UMLS CUI [1,6]
C0031328
UMLS CUI [1,7]
C0178913
Sample Identifier/Sample Number
Descrizione

Sample Identifier and Sample Number are conditional. The study team must choose one for inclusion on the eCRF form.

Tipo di dati

integer

Alias
UMLS CUI [1]
C1299222
Ritorna all'inizio della pagina

Similar models

Pharmacokinetics (Liver PK), Liver Event 4-DF

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
An unscheduled PK blood sample must be obtained within 24 hours of last dose (or 3x the investigational product half-life or t1/2; protocol specified longer value to be inserted).
C3854240 (UMLS CUI-1)
C0031327 (UMLS CUI-2)
C0005834 (UMLS CUI-3)
C3843067 (UMLS CUI-4)
C0946444 (UMLS CUI-5)
C0013230 (UMLS CUI-6)
pharmacokinetic blood sample
Item
1. Was a pharmacokinetic blood sample obtained?
boolean
C0031328 (UMLS CUI [1,1])
C0005834 (UMLS CUI [1,2])
date blood sample taken
Item
If yes, date sample taken
date
C0005834 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
time blood sample taken
Item
If yes, time sample taken
time
C0005834 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
date last investigational product dose prior to PK sample
Item
If Yes, date of last investigational product dose prior to PK sample
date
C0011008 (UMLS CUI [1,1])
C1517741 (UMLS CUI [1,2])
C0678766 (UMLS CUI [1,3])
C0013230 (UMLS CUI [1,4])
C0332152 (UMLS CUI [1,5])
C0031328 (UMLS CUI [1,6])
C0178913 (UMLS CUI [1,7])
time last investigational product dose prior to PK sample
Item
If Yes, time of last investigational product dose prior to PK sample
time
C0040223 (UMLS CUI [1,1])
C1517741 (UMLS CUI [1,2])
C0678766 (UMLS CUI [1,3])
C0013230 (UMLS CUI [1,4])
C0332152 (UMLS CUI [1,5])
C0031328 (UMLS CUI [1,6])
C0178913 (UMLS CUI [1,7])
Sample Identifier/Sample Number
Item
Sample Identifier/Sample Number
integer
C1299222 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial